VolitionRx Limited Increase Decrease In Management Fee Payable
VolitionRx Limited (VNRX) reported Increase Decrease In Management Fee Payable of $26.55 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInManagementFeePayable · last filed 2026-08-13
- VolitionRx Limited increase decrease in management fee payable for the quarter ending 2026-06-30 was $38.70K.
- VolitionRx Limited increase decrease in management fee payable for the quarter ending 2026-03-31 was -$12.16K, a 150.01% decline year-over-year.
- VolitionRx Limited increase decrease in management fee payable for the quarter ending 2025-06-30 was $0.00.
- VolitionRx Limited increase decrease in management fee payable for the quarter ending 2025-03-31 was $24.31K, a 3814.01% increase year-over-year.
| Period end | Increase Decrease In Management Fee Payable 3 month | Increase Decrease In Management Fee Payable 6 month |
|---|---|---|
| 2026-06-30 | $38.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $26.55K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$12.16K 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $24.31K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $24.31K 10-Q · filed 2026-05-14 | |
| 2024-06-30 | -$35.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$34.55K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $621.00 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |